168 related articles for article (PubMed ID: 11524493)
1. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
Aksamit AJ; Preissner CM; Homburger HA
Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Beaudry P; Cohen P; Brandel JP; Delasnerie-Lauprêtre N; Richard S; Launay JM; Laplanche JL
Dement Geriatr Cogn Disord; 1999; 10(1):40-6. PubMed ID: 10068257
[TBL] [Abstract][Full Text] [Related]
3. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
[TBL] [Abstract][Full Text] [Related]
4. Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease.
Kropp S; Zerr I; Schulz-Schaeffer WJ; Riedemann C; Bodemer M; Laske C; Kretzschmar HA; Poser S
Neurosci Lett; 1999 Feb; 261(1-2):124-6. PubMed ID: 10081943
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.
Zerr I; Bodemer M; Räcker S; Grosche S; Poser S; Kretzschmar HA; Weber T
Lancet; 1995 Jun; 345(8965):1609-10. PubMed ID: 7783539
[TBL] [Abstract][Full Text] [Related]
6. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.
Zerr I; Bodemer M; Otto M; Poser S; Windl O; Kretzschmar HA; Gefeller O; Weber T
Lancet; 1996 Sep; 348(9031):846-9. PubMed ID: 8826809
[TBL] [Abstract][Full Text] [Related]
8. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease.
Kohira I; Tsuji T; Ishizu H; Takao Y; Wake A; Abe K; Kuroda S
Acta Neurol Scand; 2000 Dec; 102(6):385-7. PubMed ID: 11125754
[TBL] [Abstract][Full Text] [Related]
9. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
Green AJ
Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
[TBL] [Abstract][Full Text] [Related]
10. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y
Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory and imaging studies for the diagnosis of prion disease].
Shiga Y; Miyazawa K; Takeda A; Arai H; Doh-ura K; Itoyama Y
Rinsho Shinkeigaku; 2003 Nov; 43(11):810-2. PubMed ID: 15152471
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
15. Early elevation of cerebrospinal fluid neuron-specific enolase in Creutzfeldt-Jakob disease.
Evers S; Droste DW; Lüdemann P; Oberwittler C
J Neurol; 1998 Jan; 245(1):52-3. PubMed ID: 9457631
[No Abstract] [Full Text] [Related]
16. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
Chapman T; McKeel DW; Morris JC
Neurology; 2000 Nov; 55(9):1396-7. PubMed ID: 11087791
[TBL] [Abstract][Full Text] [Related]
17. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease.
Cambier DM; Kantarci K; Worrell GA; Westmoreland BF; Aksamit AJ
Clin Neurophysiol; 2003 Sep; 114(9):1724-8. PubMed ID: 12948802
[TBL] [Abstract][Full Text] [Related]
18. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.
Peoc'h K; Schröder HC; Laplanche J; Ramljak S; Müller WE
Neurosci Lett; 2001 Apr; 301(3):167-70. PubMed ID: 11257424
[TBL] [Abstract][Full Text] [Related]
19. [Diffuse reduced uptake in 99m-Tc-HM-PAO SPECT and high level of neuron-specific enolase in cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease].
Kohira I; Ishizu H; Shohmori T; Ujike H; Kuroda S; Otsuki S; Ihara Y
No To Shinkei; 1992 Jun; 44(6):579-82. PubMed ID: 1389566
[TBL] [Abstract][Full Text] [Related]
20. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
Sanchez-Juan P; Sánchez-Valle R; Green A; Ladogana A; Cuadrado-Corrales N; Mitrová E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Krasnianski A; Equestre M; Slivarichová D; Saiz A; Calero M; Pocchiari M; Knight R; van Duijn CM; Zerr I
J Neurol; 2007 Jul; 254(7):901-6. PubMed ID: 17385081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
